CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo‐controlled study
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12309
Institution: Janssen Research & Development (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Janssen Research and Development
OpenAlex ID: W2081095734
